Cargando…

TWEAK: A New Player in Obesity and Diabetes

Obesity and type 2 diabetes (T2D) are associated with chronic low-grade inflammation. Mounting evidence suggests the involvement of an inflammatory switch in adipose tissue, both in mature adipocytes and immune-competent cells from the stromal vascular compartment, in the progression of obesity and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vendrell, Joan, Chacón, Matilde R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874549/ https://www.ncbi.nlm.nih.gov/pubmed/24416031 http://dx.doi.org/10.3389/fimmu.2013.00488

Ejemplares similares

Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study
por: Llauradó, Gemma, et al.
Publicado: (2012)

TWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure
por: Novoyatleva, Tatyana, et al.
Publicado: (2014)

Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk
por: Díaz-López, Andrés, et al.
Publicado: (2014)

A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2021)

New Insights in Cytokines in Childhood Obesity: Changes in TWEAK and CD163 After a 2-Year Intervention Program in Prepubertal Children With Obesity
por: Escartín, Rocío, et al.
Publicado: (2022)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

The Role of Ubiquitination in TWEAK-Stimulated Signaling
por: Vucic, Domagoj
Publicado: (2013)

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
por: Bertin, Daniel, et al.
Publicado: (2013)

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

TWEAK and LTβ Signaling during Chronic Liver Disease
por: Dwyer, Benjamin J., et al.
Publicado: (2014)

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus
por: Elbahesh, Husni, et al.
Publicado: (2019)

Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway
por: Stock, Ariel D., et al.
Publicado: (2013)

TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
por: Carmona Arana, José Antonio, et al.
Publicado: (2014)

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
por: Blanco-Colio, Luis M.
Publicado: (2014)

Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
por: Fan, Yuxiang, et al.
Publicado: (2021)

TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease
por: Poveda, Jonay, et al.
Publicado: (2013)

TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
por: Cheng, Emily, et al.
Publicado: (2013)

TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction
por: Sato, Shuichi, et al.
Publicado: (2014)

Pro-Inflammatory and B Cell Regulating Capacities of TWEAK in Rainbow Trout (Oncorhynchus mykiss)
por: Abós, Beatriz, et al.
Publicado: (2021)

TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus
por: Liu, Yale, et al.
Publicado: (2017)

TWEAKing death
por: Ashwell, Jonathan D.
Publicado: (2008)

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
por: Zaitseva, Olena, et al.
Publicado: (2023)

Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro
por: Altuna-Coy, Antonio, et al.
Publicado: (2021)

Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2019)

Thymic B Cells as a New Player in the Type 1 Diabetes Response
por: Greaves, Richard B., et al.
Publicado: (2021)

Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
por: Escoté, Xavier, et al.
Publicado: (2017)

Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis
por: Enwere, Emeka K., et al.
Publicado: (2014)

Sirtuins: Key players in obesity-associated adipose tissue remodeling
por: Chen, Jiali, et al.
Publicado: (2022)

Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR
por: Purcell, James W., et al.
Publicado: (2014)

TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model
por: Iacobas, Dumitru A., et al.
Publicado: (2021)

Neutrophil: A New Player in Metastatic Cancers
por: Wu, Mengyue, et al.
Publicado: (2020)

Tweaking Microtubules to Treat Scleroderma
por: van Laar, Jacob M, et al.
Publicado: (2005)

Disuse TWEAKs muscle loss
por: Short, Ben
Publicado: (2010)

The “tweaking principle” for task switching
por: Ardid, Salva, et al.
Publicado: (2014)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

Regulation of Tissue Responses: The TWEAK/Fn14 Pathway and Other TNF/TNFR Superfamily Members That Activate Non-Canonical NFκB Signaling
por: Burkly, Linda C.
Publicado: (2015)

TWEAK Progress in Dermatology: A Review
por: Kharel, Pramisha, et al.
Publicado: (2023)

A new player in the dermis
por: Egawa, Gyohei, et al.
Publicado: (2021)

B Cells: The Old New Players in Reproductive Immunology
por: Fettke, Franziska, et al.
Publicado: (2014)

Neutrophil extracellular traps: New players in cancer research
por: Zhao, Junjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aevcgiuhicsor8bfk9s4sr0ces